Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis

被引:4
|
作者
Jiao, Boshen [1 ]
Basu, Anirban [1 ]
机构
[1] Univ Washington, Sch Pharm, Comparat Hlth Outcomes Policy Econ CHOICE Inst, 1959 NE Pacific St,Box 357631 H375Q, Seattle, WA 98195 USA
基金
美国国家卫生研究院;
关键词
FUTURE COSTS; STATE VALUATIONS; UNITED-STATES; INCOME; CARE; RECOMMENDATIONS; VOLUNTEER; LOSSES; PANEL; AGE;
D O I
10.1007/s40273-023-01246-x
中图分类号
F [经济];
学科分类号
02 ;
摘要
BackgroundThe Second Panel on Cost Effectiveness in Health and Medicine recommended that cost-effectiveness analyses (CEA) explicitly incorporate the valuation of productive time from a societal perspective. We developed a new approach to capture productivity impacts in CEA without direct evidence on these impacts by associating varying levels of health-related quality-of-life (HrQoL) score with different time uses in the United States.MethodsWe conceptualized a framework that estimates the association between HrQoL score with productivity through time uses. We used the American Time-Use Survey (ATUS) from year 2012-2013, when data on a Well-Being Module (WBM) was additionally collected alongside ATUS. The WBM measured the quality of life (QoL) score using a visual analog scale. To operationalize our conceptual framework, we employed an econometric approach that addressed three technical issues in the observed data: (i) distinction between overall QoL and HrQoL, (ii) correlation across different categories of time use and the share structure of time-use data, and (iii) reverse causality between time uses and HrQoL score in a cross-sectional setting. Furthermore, we developed a metamodel-based algorithm to summarize the numerous estimates from the primary econometric model efficiently. Finally, we illustrated the use of our algorithm to calculate productivity and time spent seeking care costs in an empirical CEA of a prostate cancer treatment.ResultsWe provide the estimates of the metamodel algorithm. Incorporating these estimates into the empirical CEA reduced the incremental cost-effectiveness ratio by 27%.ConclusionOur estimates can facilitate the inclusion of productivity and time spent seeking care in CEA as recommended by the Second Panel.
引用
收藏
页码:1065 / 1077
页数:13
相关论文
共 50 条
  • [1] Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis
    Boshen Jiao
    Anirban Basu
    [J]. PharmacoEconomics, 2023, 41 : 1065 - 1077
  • [2] Health-related quality of life measures for a cost-effectiveness analysis of ischemic stroke therapies
    Drugdova, Irena
    Rogalewicz, Vladimir
    Sramek, Martin
    Kopalova, Veronika
    Krahula, Ondrej
    Gavurova, Beata
    Bartak, Miroslav
    [J]. KONTAKT-JOURNAL OF NURSING AND SOCIAL SCIENCES RELATED TO HEALTH AND ILLNESS, 2020, 22 (02): : 128 - 136
  • [3] Health-related quality of life and cost-effectiveness analysis in radiology
    Zofia Kielar, Ania
    El-Maraghi, Robert H.
    Carlos, Ruth C.
    [J]. ACADEMIC RADIOLOGY, 2007, 14 (04) : 411 - 419
  • [4] The impact of weight loss on health-related quality-of-life: implications for cost-effectiveness analyses
    Amy E. Rothberg
    Laura N. McEwen
    Andrew T. Kraftson
    Gina M. Neshewat
    Christine E. Fowler
    Charles F. Burant
    William H. Herman
    [J]. Quality of Life Research, 2014, 23 : 1371 - 1376
  • [5] The impact of weight loss on health-related quality-of-life: implications for cost-effectiveness analyses
    Rothberg, Amy E.
    McEwen, Laura N.
    Kraftson, Andrew T.
    Neshewat, Gina M.
    Fowler, Christine E.
    Burant, Charles F.
    Herman, William H.
    [J]. QUALITY OF LIFE RESEARCH, 2014, 23 (04) : 1371 - 1376
  • [6] OVERVIEW OF HEALTH-RELATED QUALITY-OF-LIFE MEASURES
    MACKEIGAN, LD
    PATHAK, DS
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (09): : 2236 - 2245
  • [7] Health-related quality-of-life measures for children
    Eiser, C
    Cotter, I
    Oades, P
    Seamark, D
    Smith, R
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1999, : 87 - 90
  • [8] Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life
    Nguyen, Elaine
    Coleman, Craig I.
    Kohn, Christine G.
    Weeda, Erin R.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 34 - 38
  • [9] Health-related quality of life and cost-effectiveness of treatment in subarachnoid haemorrhage
    Malmivaara, K.
    Juvela, S.
    Hernesniemi, J.
    Lappalainen, J.
    Siironen, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (11) : 1455 - 1461
  • [10] MULTITRAIT-MULTIMETHOD ANALYSIS OF HEALTH-RELATED QUALITY-OF-LIFE MEASURES
    HADORN, DC
    HAYS, RD
    [J]. MEDICAL CARE, 1991, 29 (09) : 829 - 840